Adaptive Phage Therapeutics has entered into a collaboration and license agreement with the Israeli Phage Therapy Center of the Hebrew University of Jerusalem and Hadassah Medical Center. The agreement grants APT exclusive rights to make, use, and sell licensed phages for human therapy.